Abstract
BackgroundThe Beck Depression Inventory II (BDI-II) has been accepted as one of the most commonly used self-report measures for depression. However, there is no study examining the psychometric properties of the BDI-II among substance users in low- and middle-income countries such as Myanmar. Therefore, this study aimed to evaluate the suitability of using this instrument in substance users and to examine the reliability and diagnostic efficiency to be compared with the International Classification of Diseases (ICD-10) among substance users in Northern Shan State of Myanmar.MethodsA respondent-driven sampling (RDS) method was applied for recruiting the participants in this study, and total 230 substance users were recruited. On the other hand, 50 participants who visited the drop-in center (DIC) were screened for depressive symptoms using ICD-10 during the days when one consultant psychiatrist doctor was presented. These participants were interviewed face-to-face by the consultant psychiatrist using a semi-structured questionnaire including the Myanmar version of the BDI-II (mBDI-II).ResultsThe mBDI-II showed moderate accuracy with an area under the curve of 0.68. The optimal cutoff score was 10 with the highest Youden index (0.48), and it had high sensitivity and specificity (0.78 and 0.70). The Cronbach’s alpha coefficients for clinically depressed and non-clinically depressed substance users were 0.91 and 0.93, respectively. Confirmatory factor analysis of the mBDI-II indicated that a three-factor solution (cognitive, affective, and somatic) was the best fit for substance users.ConclusionsThe mBDI-II has sound psychometric properties among substance users with moderate accuracy and range of possible cutoff scores together with sensitivity and specificity.
Highlights
Depressive symptoms are highly prevalent among substance users and are often a comorbid condition accompanying substance-related disorder [1,2,3]
The purpose of this study was to evaluate the suitability of using this instrument and to examine the reliability and diagnostic efficiency to be compared with the International Classification of Diseases (ICD-10) among substance users in Northern Shan State of Myanmar
A respondent-driven sampling (RDS) method was applied for the main evaluation study, because RDS is known as an effective data collection method for a hidden population like substance users [22]
Summary
Depressive symptoms are highly prevalent among substance users and are often a comorbid condition accompanying substance-related disorder [1,2,3]. The 12-month prevalence of major depressive disorder among substance users was 16.1% [4], and 30 to 45% of substance users seeking treatment are affected [1]. There is a need to develop a reliable and validated screening instrument for depression that is suitable for substance users in the community setting. The Beck Depression Inventory II (BDI-II) has been accepted as one of the most commonly used self-report measures for depression. There is no study examining the psychometric properties of the BDI-II among substance users in low- and middle-income countries such as Myanmar. This study aimed to evaluate the suitability of using this instrument in substance users and to examine the reliability and diagnostic efficiency to be compared with the International Classification of Diseases (ICD-10) among substance users in Northern Shan State of Myanmar
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.